Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study

Marcel Flendrie*, Wynand HPM Vissers, Marjonne CW Creemers, Elke MGJ de Jong, Peter CM van de Kerkhof and Piet LCM van Riel

Arthritis Research & Therapy 2005, 7:R666-R676 doi:10.1186/ar1724

Accesses  

  • Last 30 days: 108 accesses
  • Last year: 1153 accesses
  • All time: 17249 accesses

Cited by

BioMed Central: 2 citations

Poster presentation   Open Access

Safety of treatment with biologics for psoriasis in daily practice: 5-year data

PPM Van Lümig, RJB Driessen, MAM Berends, J B Boezeman, PCM van de Kerkhof, EMGJ de Jong Journal of Translational Medicine 2010, 8(Suppl 1):P16 (25 November 2010)

Full text | PDF

Research article   Open Access Highly Accessed

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia Arthritis Research & Therapy 2009, 11:R95 (23 June 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | Editor’s summary

A small clinical trial has shown masitinib to be generally well tolerated and effective in the treatment of rheumatoid arthritis, indicating the need for further placebo-controlled studies.

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations